First Republic Investment Management, Inc. Ardelyx, Inc. Transaction History

First Republic Investment Management, Inc.

  • $34.7 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$0.51 - $1.17 $5,100 - $11,700
-10,000 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.65 - $1.18 $861 - $1,563
-1,325 Reduced 11.7%
10,000 $11,000
Q4 2021

Feb 09, 2022
SELL
$0.86 - $1.7 $1,062 - $2,099
-1,235 Reduced 9.83%
11,325 $12,000
Q3 2021

Nov 12, 2021
BUY
$1.27 - $8.17 $15,951 - $102,615
12,560 New
12,560 $17,000

Others Institutions Holding ARDX

# of Institutions
209
Shares Held
144M
Call Options Held
1.01M
Put Options Held
1.43M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $994M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email